1
项与 HerinCAR-PD1 cells(Shanghai Cell Therapy Research Institute) 相关的临床试验A Clinical Study of PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor
To evaluate the safety and effectiveness of cell therapy using herinCAR-PD1 cells to treat advanced cancer.
Individuals greater than or equal to 18 years of age and less than or equal to 70 years of age who have been diagnosed with relapsed or refractory cancer that has not responded to or has relapsed after standard treatment.
100 项与 HerinCAR-PD1 cells(Shanghai Cell Therapy Research Institute) 相关的临床结果
100 项与 HerinCAR-PD1 cells(Shanghai Cell Therapy Research Institute) 相关的转化医学
100 项与 HerinCAR-PD1 cells(Shanghai Cell Therapy Research Institute) 相关的专利(医药)
100 项与 HerinCAR-PD1 cells(Shanghai Cell Therapy Research Institute) 相关的药物交易